Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 324

1.

Lack of association between Toxocara canis and multiple sclerosis: A population-based case-control study.

Cicero CE, Patti F, Lo Fermo S, Giuliano L, Rascunà C, Chisari CG, D'Amico E, Paradisi V, Marin B, Preux PM, Mantella A, Bartoloni A, Zappia M, Nicoletti A.

Mult Scler. 2019 Feb 11:1352458518825394. doi: 10.1177/1352458518825394. [Epub ahead of print] No abstract available.

PMID:
30741090
2.

Newest evidence for tetrahydrocannabinol:cannabidiol oromucosal spray from postapproval pragmatic studies.

Patti F.

Neurodegener Dis Manag. 2019 Apr;9(2s):3-7. doi: 10.2217/nmt-2018-0049. Epub 2019 Jan 18.

PMID:
30657027
3.

Chiral optical tweezers for optically active particles in the T-matrix formalism.

Patti F, Saija R, Denti P, Pellegrini G, Biagioni P, Iatì MA, Maragò OM.

Sci Rep. 2019 Jan 10;9(1):29. doi: 10.1038/s41598-018-36434-9.

4.

Discontinuation of teriflunomide and dimethyl fumarate in a large Italian multicentre population: a 24-month real-world experience.

D'Amico E, Zanghì A, Sciandra M, Borriello G, Callari G, Gallo A, Salemi G, Cottone S, Buccafusca M, Valentino P, Bossio RB, Grimaldi LME, Pozzilli C, Tedeschi G, Zappia M, Patti F.

J Neurol. 2019 Feb;266(2):411-416. doi: 10.1007/s00415-018-9144-9. Epub 2018 Dec 4.

PMID:
30515629
5.

Effectiveness and safety of Rituximab in demyelinating diseases spectrum: An Italian experience.

D'Amico E, Zanghì A, Chisari CG, Fermo SL, Toscano S, Arena S, Patti F, Zappia M.

Mult Scler Relat Disord. 2019 Jan;27:324-326. doi: 10.1016/j.msard.2018.09.041. Epub 2018 Oct 3.

PMID:
30471585
6.

The Italian multiple sclerosis register.

Trojano M, Bergamaschi R, Amato MP, Comi G, Ghezzi A, Lepore V, Marrosu MG, Mosconi P, Patti F, Ponzio M, Zaratin P, Battaglia MA; Italian Multiple Sclerosis Register Centers Group.

Neurol Sci. 2019 Jan;40(1):155-165. doi: 10.1007/s10072-018-3610-0. Epub 2018 Nov 13.

7.

Noise⁻Seeded Developmental Pattern Formation in Filamentous Cyanobacteria.

Arbel-Goren R, Di Patti F, Fanelli D, Stavans J.

Life (Basel). 2018 Nov 9;8(4). pii: E58. doi: 10.3390/life8040058. Review.

8.

Authors' Response to the Letter to the Editor Regarding: A Comprehensive Review on Copemyl®.

Annovazzi P, Bertolotto A, Brescia Morra V, Gasperini C, Montanari E, Navarra P, Patti F, Pia Sormani M, Ghezzi A.

Neurol Ther. 2018 Dec;7(2):391-393. doi: 10.1007/s40120-018-0116-x. Epub 2018 Nov 10. No abstract available.

9.

No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study.

Prosperini L, Annovazzi P, Boffa L, Buscarinu MC, Gallo A, Matta M, Moiola L, Musu L, Perini P, Avolio C, Barcella V, Bianco A, Farina D, Ferraro E, Pontecorvo S, Granella F, Grimaldi LME, Laroni A, Lus G, Patti F, Pucci E, Pasca M, Sarchielli P; Italian Alemtuzumab Study Group.

J Neurol. 2018 Dec;265(12):2851-2860. doi: 10.1007/s00415-018-9070-x. Epub 2018 Sep 26.

PMID:
30259178
10.

Static postural control disturbances among the different multiple sclerosis phenotypes: A Neurocom Balance Manager® evaluation study.

Cimino V, Chisari CG, Raciti G, Pappalardo A, Zappia M, Patti F.

Mult Scler Relat Disord. 2018 Nov;26:46-51. doi: 10.1016/j.msard.2018.08.024. Epub 2018 Sep 8.

PMID:
30223228
11.

Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-word multicenter experience.

D'Amico E, Zanghì A, Callari G, Borriello G, Gallo A, Graziano G, Valentino P, Buccafusca M, Cottone S, Salemi G, Ragonese P, Bossio RB, Docimo R, Grimaldi LME, Pozzilli C, Tedeschi G, Zappia M, Patti F.

Ther Adv Neurol Disord. 2018 Sep 10;11:1756286418796404. doi: 10.1177/1756286418796404. eCollection 2018.

12.

Predictors of relapse and disability progression in MS patients who discontinue disease-modifying therapy.

Kister I, Spelman T, Patti F, Duquette P, Trojano M, Izquierdo G, Lugaresi A, Grammond P, Sola P, Ferraro D, Grand'Maison F, Alroughani R, Terzi M, Boz C, Hupperts R, Lechner-Scott J, Kappos L, Pucci E, Hodgkinson S, Solaro C, Butzkueven H.

J Neurol Sci. 2018 Aug 15;391:72-76. doi: 10.1016/j.jns.2018.06.001. Epub 2018 Jun 2.

PMID:
30103975
13.

Patient and caregiver involvement in the formulation of guideline questions: findings from the European Academy of Neurology guideline on palliative care of people with severe multiple sclerosis.

Köpke S, Giordano A, Veronese S, Christin Rahn A, Kleiter I, Basedow-Rajwich B, Fornari A, Battaglia MA, Drulovic J, Kooij L, Koops J, Mens J, Meza Murillo ER, Milanov I, Milo R, Patti F, Pekmezovic T, Sastre-Garriga J, Vosburgh J, Voltz R, Bay J, Oliver DJ, Solari A.

Eur J Neurol. 2019 Jan;26(1):41-50. doi: 10.1111/ene.13760. Epub 2018 Sep 9.

PMID:
30035845
14.

Participant perspectives of a home-based palliative approach for people with severe multiple sclerosis: A qualitative study.

Giovannetti AM, Borreani C, Bianchi E, Giordano A, Cilia S, Cipollari S, Rossi I, Cavallaro C, Torri Clerici V, Rossetti E, Stefanelli MC, Totis A, Pappalardo A, Occhipinti G, Confalonieri P, Veronese S, Grasso MG, Patti F, Zaratin P, Battaglia MA, Solari A; PeNSAMI project.

PLoS One. 2018 Jul 12;13(7):e0200532. doi: 10.1371/journal.pone.0200532. eCollection 2018.

15.

Late-onset and young-onset relapsing-remitting multiple sclerosis: evidence from a retrospective long-term follow-up study.

D'Amico E, Patti F, Zanghì A, Chisari CG, Lo Fermo S, Zappia M.

Eur J Neurol. 2018 Dec;25(12):1425-1431. doi: 10.1111/ene.13745. Epub 2018 Aug 3.

PMID:
29956427
16.

Cognitive assessment in multiple sclerosis-an Italian consensus.

Amato MP, Morra VB, Falautano M, Ghezzi A, Goretti B, Patti F, Riccardi A, Mattioli F.

Neurol Sci. 2018 May 15. doi: 10.1007/s10072-018-3427-x. [Epub ahead of print]

PMID:
29766386
17.

eMSQOL-29: Prospective validation of the abbreviated, electronic version of MSQOL-54.

Rosato R, Testa S, Bertolotto A, Scavelli F, Giovannetti AM, Confalonieri P, Patti F, Chisari CG, Lugaresi A, Pietrolongo E, Grasso MG, Rossi I, Toscano A, Loera B, Giordano A, Solari A.

Mult Scler. 2018 May 1:1352458518774935. doi: 10.1177/1352458518774935. [Epub ahead of print]

PMID:
29761738
18.

Hopping in the Crowd to Unveil Network Topology.

Asllani M, Carletti T, Di Patti F, Fanelli D, Piazza F.

Phys Rev Lett. 2018 Apr 13;120(15):158301. doi: 10.1103/PhysRevLett.120.158301.

PMID:
29756854
19.

Robust stochastic Turing patterns in the development of a one-dimensional cyanobacterial organism.

Di Patti F, Lavacchi L, Arbel-Goren R, Schein-Lubomirsky L, Fanelli D, Stavans J.

PLoS Biol. 2018 May 4;16(5):e2004877. doi: 10.1371/journal.pbio.2004877. eCollection 2018 May.

20.

Lateral switch to IFN beta-1a 44 mcg may be effective as escalation switch to fingolimod in selected persons with relapsing remitting multiple sclerosis: a real-world setting experience.

D'Amico E, Patti F, Zanghì A, Lo Fermo S, Chisari CG, Zappia M.

Expert Rev Clin Pharmacol. 2018 May;11(5):531-536. doi: 10.1080/17512433.2018.1449643. Epub 2018 Mar 13.

PMID:
29521113
21.

Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks.

Portaccio E, Annovazzi P, Ghezzi A, Zaffaroni M, Moiola L, Martinelli V, Lanzillo R, Brescia Morra V, Rinaldi F, Gallo P, Tortorella C, Paolicelli D, Pozzilli C, De Giglio L, Cavalla P, Cocco E, Marrosu MG, Patti F, Solaro C, Bellantonio P, Uccelli A, Laroni A, Pastò L, Giannini M, Trojano M, Comi G, Amato MP; MS Study Group of the Italian Neurological Society.

Neurology. 2018 Mar 6;90(10):e823-e831. doi: 10.1212/WNL.0000000000005067. Epub 2018 Feb 7.

PMID:
29438046
22.

Identifying neuropathic pain in patients with multiple sclerosis: a cross-sectional multicenter study using highly specific criteria.

Solaro C, Cella M, Signori A, Martinelli V, Radaelli M, Centonze D, Sica F, Grasso MG, Clemenzi A, Bonavita S, Esposito S, Patti F, D'Amico E, Cruccu G, Truini A; Neuropathic Pain Special Interest Group of the Italian Neurological Society.

J Neurol. 2018 Apr;265(4):828-835. doi: 10.1007/s00415-018-8758-2. Epub 2018 Feb 5.

PMID:
29404736
23.

Botulinum Toxin A for Sialorrhoea Associated with Neurological Disorders: Evaluation of the Relationship between Effect of Treatment and the Number of Glands Treated.

Restivo DA, Panebianco M, Casabona A, Lanza S, Marchese-Ragona R, Patti F, Masiero S, Biondi A, Quartarone A.

Toxins (Basel). 2018 Jan 27;10(2). pii: E55. doi: 10.3390/toxins10020055.

24.

Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational study.

Baroncini D, Zaffaroni M, Moiola L, Lorefice L, Fenu G, Iaffaldano P, Simone M, Fanelli F, Patti F, D'Amico E, Capobianco M, Bertolotto A, Gallo P, Margoni M, Miante S, Milani N, Amato MP, Righini I, Bellantonio P, Scandellari C, Costantino G, Scarpini E, Bergamaschi R, Mallucci G, Comi G, Ghezzi A; iMED Registry and Gruppo di Studio SM-Società Italiana di Neurologia.

Mult Scler. 2018 Jan 1:1352458518754364. doi: 10.1177/1352458518754364. [Epub ahead of print]

PMID:
29363396
25.

Pharmacokinetic drug evaluation of daclizumab for the treatment of relapsing-remitting multiple sclerosis.

Patti F, Chisari CG, D'Amico E, Zappia M.

Expert Opin Drug Metab Toxicol. 2018 Mar;14(3):341-352. doi: 10.1080/17425255.2018.1432594. Epub 2018 Jan 30. Review.

PMID:
29363337
26.

Beyond Disease: Happiness, Goals, and Meanings among Persons with Multiple Sclerosis and Their Caregivers.

Delle Fave A, Bassi M, Allegri B, Cilia S, Falautano M, Goretti B, Grobberio M, Minacapelli E, Pattini M, Pietrolongo E, Valsecchi M, Amato MP, Lugaresi A, Patti F.

Front Psychol. 2017 Dec 20;8:2216. doi: 10.3389/fpsyg.2017.02216. eCollection 2017.

27.

Single incision extended video assisted transcervical thymectomy.

Migliore M, Criscione A, Nardini M, Patti F, Borrata F.

J Vis Surg. 2017 Oct 28;3:154. doi: 10.21037/jovs.2017.10.06. eCollection 2017. No abstract available.

28.

Correction to: Management of pregnancy-related issues in multiple sclerosis patients: the need for an interdisciplinary approach.

Amato MP, Bertolotto A, Brunelli R, Cavalla P, Goretti B, Marrosu MG, Patti F, Pozzilli C, Provinciali L, Rizzo N, Strobelt N, Tedeschi G, Trojano M, Comi G.

Neurol Sci. 2018 Feb;39(2):395. doi: 10.1007/s10072-017-3226-9.

PMID:
29280018
29.

Standardised Frankincense extract: new possible therapeutic option for patients with relapsing-remitting multiple sclerosis.

Patti F.

J Neurol Neurosurg Psychiatry. 2018 Apr;89(4):327. doi: 10.1136/jnnp-2017-317380. Epub 2017 Dec 23. No abstract available.

PMID:
29275327
30.

Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing-remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study).

Comi G, Patti F, Rocca MA, Mattioli FC, Amato MP, Gallo P, Centonze D, Pozzilli C, Saccà F, Bergh FT, Bartezaghi M, Turrini R, Filippi M; Golden Study Group.

J Neurol. 2017 Dec;264(12):2436-2449. doi: 10.1007/s00415-017-8642-5. Epub 2017 Oct 23.

31.

The clinical value of Coop/Wonca charts in assessment of HRQoL in a large cohort of relapsing-remitting multiple sclerosis patients: Results of a multicenter study.

Pappalardo A, Chisari CG, Montanari E, Pesci I, Borriello G, Pozzilli C, D'Amico E, Patti F.

Mult Scler Relat Disord. 2017 Oct;17:154-171. doi: 10.1016/j.msard.2017.07.022. Epub 2017 Jul 28.

PMID:
29055451
32.

Highly efficient DNA-free gene disruption in the agricultural pest Ceratitis capitata by CRISPR-Cas9 ribonucleoprotein complexes.

Meccariello A, Monti SM, Romanelli A, Colonna R, Primo P, Inghilterra MG, Del Corsano G, Ramaglia A, Iazzetti G, Chiarore A, Patti F, Heinze SD, Salvemini M, Lindsay H, Chiavacci E, Burger A, Robinson MD, Mosimann C, Bopp D, Saccone G.

Sci Rep. 2017 Aug 30;7(1):10061. doi: 10.1038/s41598-017-10347-5.

33.

Pesticide exposure assessed through agricultural crop proximity and risk of amyotrophic lateral sclerosis.

Vinceti M, Filippini T, Violi F, Rothman KJ, Costanzini S, Malagoli C, Wise LA, Odone A, Signorelli C, Iacuzio L, Arcolin E, Mandrioli J, Fini N, Patti F, Lo Fermo S, Pietrini V, Teggi S, Ghermandi G, Scillieri R, Ledda C, Mauceri C, Sciacca S, Fiore M, Ferrante M.

Environ Health. 2017 Aug 29;16(1):91. doi: 10.1186/s12940-017-0297-2.

34.

A multicenter, observational, prospective study of self- and parent-reported quality of life in adolescent multiple sclerosis patients self-administering interferon-β1a using RebiSmart™-the FUTURE study.

Ghezzi A, Bianchi A, Baroncini D, Bertolotto A, Malucchi S, Bresciamorra V, Lanzillo R, Milani N, Martinelli V, Patti F, Chisari C, Rottoli M, Simone M, Paolicelli D, Visconti A; FUTURE Study Group.

Neurol Sci. 2017 Nov;38(11):1999-2005. doi: 10.1007/s10072-017-3091-6. Epub 2017 Aug 22.

PMID:
28831635
35.

Management of pregnancy-related issues in multiple sclerosis patients: the need for an interdisciplinary approach.

Amato MP, Bertolotto A, Brunelli R, Cavalla P, Goretti B, Marrosu MG, Patti F, Pozzilli C, Provinciali L, Rizzo N, Strobelt N, Tedeschi G, Trojano M, Comi G.

Neurol Sci. 2017 Oct;38(10):1849-1858. doi: 10.1007/s10072-017-3081-8. Epub 2017 Aug 2. Erratum in: Neurol Sci. 2017 Dec 26;:.

PMID:
28770366
36.

Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study).

Messina S, Solaro C, Righini I, Bergamaschi R, Bonavita S, Bossio RB, Brescia Morra V, Costantino G, Cavalla P, Centonze D, Comi G, Cottone S, Danni MC, Francia A, Gajofatto A, Gasperini C, Zaffaroni M, Petrucci L, Signoriello E, Maniscalco GT, Spinicci G, Matta M, Mirabella M, Pedà G, Castelli L, Rovaris M, Sessa E, Spitaleri D, Paolicelli D, Granata A, Zappia M, Patti F; SA.FE. study group.

PLoS One. 2017 Aug 1;12(8):e0180651. doi: 10.1371/journal.pone.0180651. eCollection 2017.

37.

A Comprehensive Review on Copemyl®.

Annovazzi P, Bertolotto A, Brescia Morra V, Gasperini C, Montanari E, Navarra P, Patti F, Sormani MP, Ghezzi A.

Neurol Ther. 2017 Dec;6(2):161-173. doi: 10.1007/s40120-017-0079-3. Epub 2017 Jul 31. Review.

38.

Patients with paediatric-onset multiple sclerosis are at higher risk of cognitive impairment in adulthood: An Italian collaborative study.

Ruano L, Branco M, Portaccio E, Goretti B, Niccolai C, Patti F, Chisari C, Gallo P, Grossi P, Ghezzi A, Roscio M, Mattioli F, Stampatori C, Simone M, Viterbo RG, Amato MP.

Mult Scler. 2018 Aug;24(9):1234-1242. doi: 10.1177/1352458517717341. Epub 2017 Jun 27.

PMID:
28654357
39.

Computer-assisted cognitive rehabilitation on freezing of gait in Parkinson's disease: A pilot study.

Dibilio V, Nicoletti A, Mostile G, Portaro G, Luca A, Patti F, Zappia M.

Neurosci Lett. 2017 Jul 27;654:38-41. doi: 10.1016/j.neulet.2017.06.006. Epub 2017 Jun 9.

PMID:
28606769
40.

Magnetic fields exposure from high-voltage power lines and risk of amyotrophic lateral sclerosis in two Italian populations.

Vinceti M, Malagoli C, Fabbi S, Kheifets L, Violi F, Poli M, Caldara S, Sesti D, Violanti S, Zanichelli P, Notari B, Fava R, Arena A, Calzolari R, Filippini T, Iacuzio L, Arcolin E, Mandrioli J, Fini N, Odone A, Signorelli C, Patti F, Zappia M, Pietrini V, Oleari P, Teggi S, Ghermandi G, Dimartino A, Ledda C, Mauceri C, Sciacca S, Fiore M, Ferrante M.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Nov;18(7-8):583-589. doi: 10.1080/21678421.2017.1332078. Epub 2017 Jun 1.

PMID:
28569083
41.

Prognostic indicators in pediatric clinically isolated syndrome.

Iaffaldano P, Simone M, Lucisano G, Ghezzi A, Coniglio G, Brescia Morra V, Salemi G, Patti F, Lugaresi A, Izquierdo G, Bergamaschi R, Cabrera-Gomez JA, Pozzilli C, Millefiorini E, Alroughani R, Boz C, Pucci E, Zimatore GB, Sola P, Lus G, Maimone D, Avolio C, Cocco E, Sajedi SA, Costantino G, Duquette P, Shaygannejad V, Petersen T, Fernández Bolaños R, Paolicelli D, Tortorella C, Spelman T, Margari L, Amato MP, Comi G, Butzkueven H, Trojano M; Italian iMedWeb Registry and the MSBase Registry.

Ann Neurol. 2017 May;81(5):729-739. doi: 10.1002/ana.24938.

PMID:
28439957
42.

Multiple sclerosis and amyotrophic lateral sclerosis: a human leukocyte antigen challenge.

Dattola V, Famà F, Russo M, Calabrò RS, Logiudice AL, Grasso MG, Patti F, Buccafusca M.

Neurol Sci. 2017 Aug;38(8):1501-1503. doi: 10.1007/s10072-017-2939-0. Epub 2017 Apr 18.

PMID:
28421301
43.

Effects of closed-loop stimulation vs. DDD pacing on haemodynamic variations and occurrence of syncope induced by head-up tilt test in older patients with refractory cardioinhibitory vasovagal syncope: the Tilt test-Induced REsponse in Closed-loop Stimulation multicentre, prospective, single blind, randomized study.

Palmisano P, Dell'Era G, Russo V, Zaccaria M, Mangia R, Bortnik M, De Vecchi F, Giubertoni A, Patti F, Magnani A, Nigro G, Rago A, Occhetta E, Accogli M.

Europace. 2018 May 1;20(5):859-866. doi: 10.1093/europace/eux015.

PMID:
28407148
44.

Randomized controlled trial of a home-based palliative approach for people with severe multiple sclerosis.

Solari A, Giordano A, Patti F, Grasso MG, Confalonieri P, Palmisano L, Ponzio M, Borreani C, Rosato R, Veronese S, Zaratin P, Battaglia MA; PeNSAMI Project.

Mult Scler. 2018 Apr;24(5):663-674. doi: 10.1177/1352458517704078. Epub 2017 Apr 6.

45.

Half-dose fingolimod for treating relapsing-remitting multiple sclerosis: Observational study.

Zecca C, Merlini A, Disanto G, Rodegher M, Panicari L, Romeo MAL, Candrian U, Messina MJ, Pravatà E, Moiola L, Stefanin C, Ghezzi A, Perrone P, Patti F, Comi G, Gobbi C, Martinelli V.

Mult Scler. 2018 Feb;24(2):167-174. doi: 10.1177/1352458517694089. Epub 2017 Feb 1.

PMID:
28273776
46.

Molecular response of Sargassum vulgare to acidification at volcanic CO2 vents: insights from de novo transcriptomic analysis.

Kumar A, Castellano I, Patti FP, Delledonne M, Abdelgawad H, Beemster GTS, Asard H, Palumbo A, Buia MC.

Mol Ecol. 2017 Apr;26(8):2276-2290. doi: 10.1111/mec.14034. Epub 2017 Mar 6.

PMID:
28133853
47.

Cognitive-motor dual-task interference: A systematic review of neural correlates.

Leone C, Feys P, Moumdjian L, D'Amico E, Zappia M, Patti F.

Neurosci Biobehav Rev. 2017 Apr;75:348-360. doi: 10.1016/j.neubiorev.2017.01.010. Epub 2017 Jan 16. Review.

PMID:
28104413
48.

Migraine causes retinal and choroidal structural changes: evaluation with ocular coherence tomography.

Reggio E, Chisari CG, Ferrigno G, Patti F, Donzuso G, Sciacca G, Avitabile T, Faro S, Zappia M.

J Neurol. 2017 Mar;264(3):494-502. doi: 10.1007/s00415-016-8364-0. Epub 2016 Dec 27.

PMID:
28028626
49.

Can new chemical therapies improve the management of multiple sclerosis in children?

D'Amico E, Zanghì A, Patti F.

Expert Opin Pharmacother. 2017 Jan;18(1):45-55. doi: 10.1080/14656566.2016.1267139. Epub 2016 Dec 16. Review.

PMID:
27901353
50.

Supplemental Content

Support Center